Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

NCT01583218 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

7513

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thromboembolism (VTE)

Interventions

DRUG: Betrixaban
DRUG: Enoxaparin

Sponsor

Portola Pharmaceuticals